XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 807,747 $ 1,652
Accounts receivable, less allowance for doubtful accounts of $0 and $0, respectively 39,172 6,075
Inventory 87,104 9,834
Note receivable - current 75,000
Prepaid expenses - current 210,351 64,911
Total current assets 1,144,374 157,472
Property and equipment, at cost less accumulated depreciation of $26,775 and $20,248, respectively 59,619 11,148
Other assets:    
Deposits 48,726 11,687
Prepaid expenses - noncurrent 2,365,719
Note receivable - noncurrent 19,389 39,000
Goodwill (Note 4) 55,849
Total other assets 2,489,683 50,687
Total assets 3,693,675 219,307
Current liabilities:    
Notes and loans payable 19,205 193,504
Derivative Liability 1,451,137
Accounts payable 73,059 143,274
Accrued officers compensation 68,750 98,750
Other accrued expenses payable 43,778 62,539
Total current liabilities and total liabilities 204,792 1,949,204
Commitments and contingencies (Notes 14)
Stockholders' deficiency:    
Common stock, no par value; authorized 750,000,000 shares, issued and outstanding 440,566,325 and 225,572,323 shares, respectively 16,624,557 12,524,042
Additional Paid-in capital 872,976 149,850
Additional Paid-in capital - Stock Options (Note 12) 202,200
Accumulated deficit (18,768,753) (14,647,476)
Total stockholders' deficiency 3,488,883 (1,729,897)
Total liabilities and stockholders' deficiency 3,693,675 219,307
Series A Preferred Stock [Member]    
Stockholders' deficiency:    
Preferred stock, authorized 5,000,000 shares: 4,557,424 243,537
Series B Preferred Stock [Member]    
Stockholders' deficiency:    
Preferred stock, authorized 5,000,000 shares: $ 479 $ 150